Joseph Yeboah to Antihypertensive Agents
This is a "connection" page, showing publications Joseph Yeboah has written about Antihypertensive Agents.
Connection Strength
0.829
-
German CA, McEvoy JW, Blaha MJ, Bertoni A, Miedema MD, Burke GL, Yeboah J. Implications of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline in a Modern Primary Prevention Multi-Ethnic Prospective Cohort (Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2019 04 01; 123(7):1076-1082.
Score: 0.544
-
Branch M, German C, Bertoni A, Yeboah J. Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial. J Diabetes Complications. 2019 07; 33(7):468-472.
Score: 0.139
-
McEvoy JW, Martin SS, Dardari ZA, Miedema MD, Sandfort V, Yeboah J, Budoff MJ, Goff DC, Psaty BM, Post WS, Nasir K, Blumenthal RS, Blaha MJ. Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy. Circulation. 2017 Jan 10; 135(2):153-165.
Score: 0.117
-
Townsend RR, Chang TI, Cohen DL, Cushman WC, Evans GW, Glasser SP, Haley WE, Olney C, Oparil S, Del Pinto R, Pisoni R, Taylor AA, Umanath K, Wright JT, Yeboah J. Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. J Am Soc Hypertens. 2016 11; 10(11):847-856.
Score: 0.029